Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

14.0%

6 terminated out of 43 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

19%

8 trials in Phase 3/4

Results Transparency

37%

10 of 27 completed with results

Key Signals

10 with results82% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (12)
Early P 1 (1)
P 1 (3)
P 2 (5)
P 3 (8)

Trial Status

Completed27
Terminated6
Withdrawn4
Unknown3
Active Not Recruiting2
Recruiting1

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT00819208Not ApplicableCompleted

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

NCT00477958Not ApplicableActive Not RecruitingPrimary

Assessment Tool for Older Patients With Cancer

NCT01721343Not ApplicableCompletedPrimary

Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

NCT01137825Recruiting

Registry of Older Patients With Cancer

NCT01399372Phase 2Completed

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT00303914Completed

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

NCT00309933Completed

Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance

NCT01372774Phase 3CompletedPrimary

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

NCT00377156Phase 3Completed

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

NCT00031798Phase 3Terminated

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

NCT01381718Phase 2Completed

Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor

NCT00007007Not ApplicableCompletedPrimary

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

NCT00052286Not ApplicableCompleted

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

NCT00740961Terminated

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

NCT00769951CompletedPrimary

Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer

NCT01453452Not ApplicableCompleted

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

NCT00452868Early Phase 1Completed

Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain

NCT00410618CompletedPrimary

Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer

NCT01483196Not ApplicableCompletedPrimary

Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery

NCT01279681Phase 3TerminatedPrimary

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Scroll to load more

Research Network

Activity Timeline